Ticker Details
Neumora Therapeutics, Inc.
IPO Date:	September 15, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$306.27M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.26 | 4.28%
Avg Daily Range (30 D):	$0.05 | 3.29%
Avg Daily Range (90 D):	$0.08 | 4.85%

Institutional Daily Volume
Avg Daily Volume:	1.13M
Avg Daily Volume (30 D):	.62M
Avg Daily Volume (90 D):	1.48M

Trade Size
Avg Trade Size (Sh.):	156
Avg Trade Size (Sh.) (30 D):	126
Avg Trade Size (Sh.) (90 D):	183

Institutional Trades
Total Institutional Trades:	308
Avg Institutional Trade:	$1.88M
Avg Institutional Trade (30 D):	$.84M
Avg Institutional Trade (90 D):	$2.71M
Avg Institutional Trade Volume:	.28M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.4M
Avg Closing Trade (30 D):	$.84M
Avg Closing Trade (90 D):	$4.66M
Avg Closing Volume:	360.59K

News

Jun 15, 2026 @ 12:00 PM Neumora Therapeutics Reports Data from Phase 3 KOA... Source: Na

Mar 19, 2026 @ 11:27 PM NMRA Investors Have Opportunity to Join Neumora Th... Source: Schall Law Firm

Mar 16, 2026 @ 11:00 AM Neumora Therapeutics to Report Fourth Quarter and ... Source: Na

Feb 4, 2026 @ 12:00 PM Neumora Therapeutics to Participate in Gugge... Source: Na

Nov 18, 2025 @ 6:02 PM Top 3 Biotech Stocks Capitalizing on the AI Revolu... Source: Timothy Fries

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-1.23	$-.23	$-.3
Diluted EPS	$-1.23	$-.23	$-.3
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-212.75M	$-43.08M	$-53.46M
Operating Income / Loss	$-211.23M	$-42.19M	$-52.86M
Cost of Revenue
Net Cash Flow	$-7.69M	$-30.24M	$-35.46M
PE Ratio